ATC code A10

ATC codes

A Alimentary tract and metabolism

A01 Stomatological preparations

A02 Drugs for acid related disorders

A03 Drugs for functional gastrointestinal disorders

A04 Antiemetics and antinauseants

A05 Bile and liver therapy

A06 Drugs for constipation

A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents

A08 Antiobesity preparations, excluding diet products

A09 Digestives, including enzymes

A10 Drugs used in diabetes

A11 Vitamins

A12 Mineral supplements

A13 Tonics

A14 Anabolic agents for systemic use

A15 Appetite stimulants

A16 Other alimentary tract and metabolism products

ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A10 is part of the anatomical group A Alimentary tract and metabolism.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA10.^[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A10A Insulins and analogues

A10AB Insulins and analogues for injection, fast-acting

A10AB01 Insulin (human)

A10AB02 Insulin (beef)

A10AB03 Insulin (pork)

A10AB04 Insulin lispro

A10AB05 Insulin aspart

A10AB06 Insulin glulisine

A10AB30 Combinations

A10AC Insulins and analogues for injection, intermediate-acting

A10AC01 Insulin (human)

A10AC02 Insulin (beef)

A10AC03 Insulin (pork)

A10AC04 Insulin lispro

A10AC30 Combinations

A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting

A10AD01 Insulin (human)

A10AD02 Insulin (beef)

A10AD03 Insulin (pork)

A10AD04 Insulin lispro

A10AD05 Insulin aspart

A10AD06 Insulin degludec and insulin aspart

A10AD30 Combinations

A10AE Insulins and analogues for injection, long-acting

A10AE01 Insulin (human)

A10AE02 Insulin (beef)

A10AE03 Insulin (pork)

A10AE04 Insulin glargine

A10AE05 Insulin detemir

A10AE06 Insulin degludec

A10AE30 Combinations

A10AE56 Insulin degludec and liraglutide

A10AF Insulins and analogues for inhalation

A10AF01 Insulin (human)

A10B Blood glucose lowering drugs, excluding insulins

A10BD02 Metformin and sulfonylureas

A10BD03 Metformin and rosiglitazone

A10BD04 Glimepiride and rosiglitazone

A10BD05 Metformin and pioglitazone

A10BD06 Glimepiride and pioglitazone

A10BD07 Metformin and sitagliptin

A10BD08 Metformin and vildagliptin

A10BD09 Pioglitazone and alogliptin

A10BD10 Metformin and saxagliptin

A10BD11 Metformin and linagliptin

A10BD12 Pioglitazone and sitagliptin

A10BD13 Metformin and alogliptin

A10BD14 Metformin and repaglinide

A10BD15 Metformin and dapagliflozin

A10BD16 Metformin and canagliflozin

A10BD17 Metformin and acarbose

A10BD18 Metformin and gemigliptin

A10BD19 Linagliptin and empagliflozin

A10BD20 Metformin and empagliflozin

A10BD21 Saxagliptin and dapagliflozin

A10BF Alpha glucosidase inhibitors

A10BF01 Acarbose

A10BF02 Miglitol

A10BF03 Voglibose

A10BG Thiazolidinediones

A10BG01 Troglitazone

A10BG02 Rosiglitazone

A10BG03 Pioglitazone

A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors

A10BH01 Sitagliptin

A10BH02 Vildagliptin

A10BH03 Saxagliptin

A10BH04 Alogliptin

A10BH05 Linagliptin

A10BH06 Gemigliptin

A10BH51 Sitagliptin and simvastatin

A10BX Other blood glucose lowering drugs, excluding insulins

A10BX01 Guar gum

A10BX02 Repaglinide

A10BX03 Nateglinide

A10BX04 Exenatide

A10BX05 Pramlintide

A10BX06 Benfluorex

A10BX07 Liraglutide

A10BX08 Mitiglinide

A10BX09 Dapagliflozin

A10BX10 Lixisenatide

A10BX11 Canagliflozin

A10BX12 Empagliflozin

A10BX13 Albiglutide

A10BX14 Dulaglutide

A10X Other drugs used in diabetes

A10XA Aldose reductase inhibitors

A10XA01 Tolrestat

References

↑ "ATC/DDD Index 2016: code A10". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QA10". WHO Collaborating Centre for Drug Statistics Methodology.

Oral anti-diabetic drugs, insulins and insulin analogs, and other drugs used in diabetes (A10)

Insulin

Sensitizers

Biguanides	Buformin^‡ Metformin^# Phenformin^‡

TZDs/"glitazones" (PPAR)	Ciglitazone^§ Darglitazone^§ Englitazone^§ Lobeglitazone Netoglitazone^§ Pioglitazone Rivoglitazone^† Rosiglitazone Troglitazone^‡

Dual PPAR agonists	Aleglitazar^† Muraglitazar^§ Saroglitazar Tesaglitazar^§

Secretagogues

K⁺_ATP

Sulfonylureas	1st generation: Acetohexamide Carbutamide Chlorpropamide Glycyclamide Metahexamide Tolazamide Tolbutamide 2nd generation: Glibenclamide (glyburide)^# Glibornuride Glicaramide Gliclazide Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide

Meglitinides/"glinides"	Mitiglinide Nateglinide Repaglinide

GLP-1 agonists

DPP-4 inhibitors/"gliptins"

Free fatty acid receptor 1 (GPR40)

Fasiglifam^†

Analogs/other insulins

fast-acting (Insulin aspart
Insulin glulisine
Insulin lispro)
short-acting (Regular insulin)
long-acting (Insulin detemir
Insulin glargine
NPH insulin)
ultra-long-acting (Insulin degludec)
inhalable (Exubera^‡
Afrezza)

Other

Aldose reductase inhibitors	Epalrestat Fidarestat^§ Ranirestat^† Tolrestat^‡ Zenarestat^§

Alpha-glucosidase inhibitors	Acarbose Miglitol Voglibose

Amylin analog	Pramlintide

Sodium glucose transporter (SGLT2) inhibitors/"gliflozins"	Canagliflozin Dapagliflozin Empagliflozin Ipragliflozin Remogliflozin^§ Sergliflozin^§ Tofogliflozin^†

Other	Benfluorex^‡ Bromocriptine

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the 1/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.